Silgan Holdings reports Q2 adjusted EPS $1.01, consensus $1.03

Reports Q2 revenue $1.54B, consensus $1.53B. “Our businesses continued to execute in the second quarter and delivered significant adjusted EPS growth of 15%, driven by increased organic volumes in our key product categories, strong contributions from the successful integration of the Weener acquisition and continued best-in-class operating performance. Once again, our diverse portfolio, the strength of our teams, our focus on innovation and our disciplined value creation strategy continue to drive our performance and the long-term success of the Company,” said Adam Greenlee, President and CEO. “Our Q2 performance was consistent with our expectations, as the contributions from our long-term strategic initiatives drove significant growth in earnings during the quarter. Our Dispensing and Specialty Closures business delivered another quarter of record performance, with strong results in dispensing products driven by our market leading innovation, intense focus on meeting the unique needs of our customers, and expanding product and geographic presence. We have made significant progress to date on the integration of the Weener acquisition, and we are pleased with the incremental opportunities our teams are pursuing to enhance our ability to compete and win in the high growth, high value dispensing products market.”